File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3390/antibiotics12030446
- Scopus: eid_2-s2.0-85151704587
- WOS: WOS:000952878100001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka
Title | One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka |
---|---|
Authors | |
Keywords | antimicrobial resistance antimicrobial use/consumption implementation One Health Sri Lanka surveillance |
Issue Date | 1-Mar-2023 |
Publisher | MDPI |
Citation | Antibiotics, 2023, v. 12, n. 3 How to Cite? |
Abstract | Background: Sri Lanka is a low-income country, as defined by the World Bank. The country suffered further economic downturn during the COVID-19 pandemic. This situation adversely affected the prioritization of policies and programs around healthcare and public health. In particular, inflation, fuel prices, and shortage of food supplies increased struggles to implement antimicrobial resistance (AMR) programs. However, in the long run, it is crucial to gather data and evidence to plan AMR policies and track interventions. (1) Aim: To establish and reiterate the importance of prioritizing AMR programs in the One Health framework, the Fleming Fellows collected and studied antimicrobial use/consumption (AMU/AMC) and resistance (AMR) in humans, food-producing animals, and the environment. (2) Methods: A systematic and cross-sectional study was conducted between 2019 and 2021. By way of coordinating an AMU/AMC and AMR prevalence study across six agencies from human health and food-producing animal sectors, the authors established a field epidemiology study, laboratory testing, and data processing at their institutions. AMU/AMC patterns were surveyed using questionnaires and interviews, while AMR samples were collected for antibiotic susceptibility tests and genomic tests. Samples were tested for phenotypic and genotypic resistance. (3) Results: In human samples, resistance was highest to beta-lactam antibiotics. In non-human samples, resistance was highest to erythromycin, a highest-priority, critically important antibiotic defined by the World Health Organization. From government records, tylosin was sold the most in the food-producing animal sector. (4) Conclusions: Sri Lanka AMU and AMR trends in human and non-human sectors can be ascertained by a One Health framework. Further coordinated, consistent, and sustainable planning is feasible, and can help implement an AMU/AMR surveillance system in Sri Lanka. |
Persistent Identifier | http://hdl.handle.net/10722/337057 |
ISSN | 2023 Impact Factor: 4.3 2023 SCImago Journal Rankings: 0.920 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ariyawansa, S | - |
dc.contributor.author | Gunawardana, KN | - |
dc.contributor.author | Hapudeniya, MM | - |
dc.contributor.author | Manelgamage, NJ | - |
dc.contributor.author | Karunarathne, CR | - |
dc.contributor.author | Madalagama, RP | - |
dc.contributor.author | Ubeyratne, KH | - |
dc.contributor.author | Wickramasinghe, D | - |
dc.contributor.author | Tun, HM | - |
dc.contributor.author | Wu, P | - |
dc.contributor.author | Lam, TTY | - |
dc.contributor.author | Chan, OSK | - |
dc.date.accessioned | 2024-03-11T10:17:46Z | - |
dc.date.available | 2024-03-11T10:17:46Z | - |
dc.date.issued | 2023-03-01 | - |
dc.identifier.citation | Antibiotics, 2023, v. 12, n. 3 | - |
dc.identifier.issn | 2079-6382 | - |
dc.identifier.uri | http://hdl.handle.net/10722/337057 | - |
dc.description.abstract | Background: Sri Lanka is a low-income country, as defined by the World Bank. The country suffered further economic downturn during the COVID-19 pandemic. This situation adversely affected the prioritization of policies and programs around healthcare and public health. In particular, inflation, fuel prices, and shortage of food supplies increased struggles to implement antimicrobial resistance (AMR) programs. However, in the long run, it is crucial to gather data and evidence to plan AMR policies and track interventions. (1) Aim: To establish and reiterate the importance of prioritizing AMR programs in the One Health framework, the Fleming Fellows collected and studied antimicrobial use/consumption (AMU/AMC) and resistance (AMR) in humans, food-producing animals, and the environment. (2) Methods: A systematic and cross-sectional study was conducted between 2019 and 2021. By way of coordinating an AMU/AMC and AMR prevalence study across six agencies from human health and food-producing animal sectors, the authors established a field epidemiology study, laboratory testing, and data processing at their institutions. AMU/AMC patterns were surveyed using questionnaires and interviews, while AMR samples were collected for antibiotic susceptibility tests and genomic tests. Samples were tested for phenotypic and genotypic resistance. (3) Results: In human samples, resistance was highest to beta-lactam antibiotics. In non-human samples, resistance was highest to erythromycin, a highest-priority, critically important antibiotic defined by the World Health Organization. From government records, tylosin was sold the most in the food-producing animal sector. (4) Conclusions: Sri Lanka AMU and AMR trends in human and non-human sectors can be ascertained by a One Health framework. Further coordinated, consistent, and sustainable planning is feasible, and can help implement an AMU/AMR surveillance system in Sri Lanka. | - |
dc.language | eng | - |
dc.publisher | MDPI | - |
dc.relation.ispartof | Antibiotics | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | antimicrobial resistance | - |
dc.subject | antimicrobial use/consumption | - |
dc.subject | implementation | - |
dc.subject | One Health | - |
dc.subject | Sri Lanka | - |
dc.subject | surveillance | - |
dc.title | One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka | - |
dc.type | Article | - |
dc.identifier.doi | 10.3390/antibiotics12030446 | - |
dc.identifier.scopus | eid_2-s2.0-85151704587 | - |
dc.identifier.volume | 12 | - |
dc.identifier.issue | 3 | - |
dc.identifier.eissn | 2079-6382 | - |
dc.identifier.isi | WOS:000952878100001 | - |
dc.identifier.issnl | 2079-6382 | - |